ID
18286
Description
A Study to Evaluate the Impact on Skin (Injection Site) Reactions of Taking an Antihistamine (Zyrtec®) or Placebo Prior to Daily Injections of Copaxone®.; ODM derived from: https://clinicaltrials.gov/show/NCT00240032
Link
https://clinicaltrials.gov/show/NCT00240032
Keywords
Versions (1)
- 10/27/16 10/27/16 -
Uploaded on
October 27, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Multiple Sclerosis NCT00240032
Eligibility Multiple Sclerosis NCT00240032
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Immunomodulation | Copaxone
Data type
boolean
Alias
- UMLS CUI [1]
- C1963758
- UMLS CUI [2]
- C0528175
Description
Injection Self Subcutaneous Unable
Data type
boolean
Alias
- UMLS CUI [1,1]
- C1828121
- UMLS CUI [1,2]
- C0036588
- UMLS CUI [1,3]
- C1522438
- UMLS CUI [1,4]
- C1299582
Description
Pregnancy | Pregnancy, Planned | Breast Feeding
Data type
boolean
Alias
- UMLS CUI [1]
- C0032961
- UMLS CUI [2]
- C0032992
- UMLS CUI [3]
- C0006147
Description
Study Subject Participation Status
Data type
boolean
Alias
- UMLS CUI [1]
- C2348568
Similar models
Eligibility Multiple Sclerosis NCT00240032
- StudyEvent: Eligibility
C1828121 (UMLS CUI [1,2])
C0036588 (UMLS CUI [1,3])
C0528175 (UMLS CUI [2])
C0036588 (UMLS CUI [1,2])
C1522438 (UMLS CUI [1,3])
C1299582 (UMLS CUI [1,4])
C0032992 (UMLS CUI [2])
C0006147 (UMLS CUI [3])
No comments